Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.32 |
| ▸ | PI4KA | P42356 | 1/20 | 0.32 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.30 |
| ▸ | NPC1 | O15118 | 2/20 | 0.30 |
| ▸ | MAPT | P10636 | 2/20 | 0.30 |
| ▸ | RAB9A | P51151 | 2/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | STAT1 | P42224 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25548245 | 0.99 | ALOX5 (0.37) | ALOX5PIK3CAPI4KAPI4KBKDM4E | |
| SCHEMBL25548225 | 0.96 | ALOX5 (0.35) | ALOX5PIK3CAPI4KAPI4KBLIMK1 | |
| SCHEMBL25548216 | 0.95 | ALOX5 (0.37) | ALOX5PIK3CAPI4KAPI4KBKDM4E | |
| SCHEMBL25548350 | 0.93 | ALOX5 (0.35) | ALOX5PIK3CAPI4KAPI4KBKDM4E | |
| SCHEMBL25548247 | 0.92 | ALOX5 (0.35) | ALOX5KDM4EMAPTMEN1ALDH1A1 | |
| SCHEMBL25548227 | 0.92 | ALOX5 (0.34) | ALOX5 | |
| SCHEMBL25548224 | 0.91 | ALOX5 (0.36) | ALOX5PIK3CAPI4KAPI4KBKDM4E | |
| SCHEMBL25548226 | 0.91 | ALOX5 (0.36) | ALOX5KDM4ENPC1MAPTRAB9A | |
| SCHEMBL25548137 | 0.89 | ALOX5 (0.41) | ALOX5KDM4ENPC1MAPTRAB9A | |
| SCHEMBL25548603 | 0.89 | ALOX5 (0.41) | ALOX5KDM4ENPC1MAPTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230167089-A1 | ORGANIC MATERIAL COMPOSITION AND APPLICATIONS THEREOF | NINGBO LUMILAN ADVANCED MATERIALS CO., LTD. (CN) | 2023-06-01 | — | — | US | disclosed |
| US-20230157161-A1 | ORGANIC MATERIAL COMPOSITION AND APPLICATIONS THEREOF | NINGBO LUMILAN ADVANCED MATERIALS CO., LTD. (CN) | 2023-05-18 | — | — | US | disclosed |
| US-20230157161-A1 | ORGANIC MATERIAL COMPOSITION AND APPLICATIONS THEREOF | NINGBO LUMILAN ADVANCED MATERIALS CO., LTD. (CN) | 2023-05-18 | — | — | US | disclosed |
| US-20230134923-A1 | ORGANIC MATERIAL COMPOSITION AND APPLICATIONS THEREOF | NINGBO LUMILAN ADVANCED MATERIALS CO., LTD. (CN) | 2023-05-04 | — | — | US | disclosed |
| US-20230134923-A1 | ORGANIC MATERIAL COMPOSITION AND APPLICATIONS THEREOF | NINGBO LUMILAN ADVANCED MATERIALS CO., LTD. (CN) | 2023-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230167089-A1 | ORGANIC MATERIAL COMPOSITION AND APPLICATIONS THEREOF | PIEZO1, VCL, VDAC3 | ALOX5 977/4885PIK3CA 593/4885PI4KA 948/4885 |
| US-20230134923-A1 | ORGANIC MATERIAL COMPOSITION AND APPLICATIONS THEREOF | PIEZO1, VCL, VDAC3 | ALOX5 977/4885PIK3CA 593/4885PI4KA 948/4885 |
| US-20230157161-A1 | ORGANIC MATERIAL COMPOSITION AND APPLICATIONS THEREOF | PIEZO1, VCL, VDAC3 | ALOX5 977/4885PIK3CA 593/4885PI4KA 948/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.